Advanced search
Publication Cover
Expert Opinion on Drug Discovery Volume 3, 2008 - Issue 8
Submit an article Journal homepage
411
Views
17
CrossRef citations to date
0
Altmetric
Reviews

Measuring the tyrosine kinase activity: a review of biochemical and cellular assay technologies

Yong Jia Group Leader Genomics Institute of the Novartis Research Foundation, Department of Kinase Biology, 10675 John J. Hopkins Dr, San Diego, CA 92121, USA +1 858 812 1728; +1 858 812 1918; [email protected]
, PhD,
Xiang-ju Gu Group Leader Genomics Institute of the Novartis Research Foundation, Department of Lead Discovery, 10675 John J. Hopkins Dr, San Diego, CA 92121, USA
, PhD,
Achim Brinker Associate Director Genomics Institute of the Novartis Research Foundation, Department of Lead Discovery, 10675 John J. Hopkins Dr, San Diego, CA 92121, USA
, PhD &
Markus Warmuth Director Genomics Institute of the Novartis Research Foundation, Department of Kinase Biology, 10675 John J. Hopkins Dr, San Diego, CA 92121, USA
, MD
Pages 959-978 | Published online: 16 Jul 2008

Bibliography

  • Manning G, Whyte DB, Martinez R, et al. The protein kinase complement of the human genome. Science 2002;298:1912-34
  • Hunter T. Signaling – 2000 and beyond. Cell 2000;100:113-27
  • Mazitschek R, Giannis A. Inhibitors of angiogenesis and cancer related receptor tyrosine kinases. Curr Opin Chem Biol 2004;8:432-41
  • Myers MR, He W, Hulme C. Inhibitors of tyrosine kinases involved in inflammation and autoimmune disease. Curr Pharm Des 1997;3:473-502
  • Vlahos CJ, McDowell SA, Clerk A. Kinases as therapeutic targets for heart failure. Nat Rev Drug Discov 2003;2:99-113
  • Resnick L, Fennell M. Targeting JNK3 for the treatment of neurodegenerative disorders. Drug Discov Today 2004;9:932-39
  • Cohen P. The development and therapeutic potential of protein kinase inhibitors. Curr Opin Chem Biol 1999;3:459-65
  • Cohen P. Protein kinases – the major drug targets of the twenty-first century? Nat Rev Drug Discov 2002;1:309-15
  • Levitzki A. Protein kinase inhibitors as a therapeutic modality. Acc Chem Res 2003;36:462-9
  • Blume-Jensen P, Hunter, T. Oncogenic kinase signaling. Nature 2001;411:355-65
  • Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000;103:211-25
  • Medinger M, Drevs J. Receptor tyrosine kinases and anticancer therapy. Curr Pharm Des 2005;11:1139-49
  • Traxler P. Tyrosine kinases as targets in cancer therapy – successes and failures. Expert Opin Ther Targets 2003;7:215-34
  • Drevs J, Medinger M, Schmidt-Gersbach C, et al. Receptor tyrosine kinases: the main targets for new cancer therapy. Curr Drug Targets 2003;4:113-21
  • Morin MJ. From oncogene to drug: development of small molecule tyrosine kinase inhibitors as anti-tumor and anti-angiogenic agents. Oncogene 2000;19:6574-83
  • Busse D, Yakes FM, Lenferink AE, Arteaga CL. Tyrosine kinase inhibitors: rationale, mechanisms of action, and implications for drug resistance. Semin Oncol 2001;28:47-55
  • Yano S, Yamaguchi M, Dong RP. EGFR tyrosine kinase inhibitor “gefitinib (Iressa)” for caner therapy. Nippon Yakurigaku Zasshi 2003;122:491-7
  • Minor L. Assays for membrance tyrosine kinase receptors: methods for high-throughput screening and utility for diagonistics. Expert Rev Mol Daign 2005;5:561-71
  • Sittampalam GS, Kahl SD, Janzen WP. High-throughput screening: advances in assay technologies. Curr Opin Chem Biol 1997;1:384-91
  • Zaman GJR, Garritsen A, de Boer TH, van Boeckel CAA. Fluorescence assays for high-throughput screening of protein kinases. Comb Chem High Throughput Screen 2003;6:313-20
  • von Ahsen O, Bömer U. High-throughput screening for kinase inhibitors. ChemBioChem 2005;6:481-90
  • Nikiforov TT, Simeonov AM. Application of fluorescence polarization to enzyme assays and single nucleotide polymorphism genotyping: some recent development. Comb Chem High Throughput Screen 2003;6:201-12
  • Boutin JA. Tyrosine protein kinase assays. J Chromotography B 1996;684:179-99
  • Schaefer EM, Guimond S. Detection of protein kinase activity using a high-capacity streptavidin-coated membrane and optimized biotinylated peptide substrate. Anal Biochem 1998;261:100-12
  • Park Y-W, Cummings RT, Wu L, et al. Homogeneous proximity tyrosine kinase assays: scintillation proximity assay versus homogeneous time-resolved fluorescence. Anal Biochem 1999;269:94-104
  • Ohml N, Wingfield JM, Yazawa H, Inagaki O. Development of a homogeneous time-resolved fluorescence assay for high-throughput screening to identify Lck inhibitors: comparison with scintillation proximity assay and streptavidin-coated plate assay. J Biomol Screen 2000;5:463-70
  • Sun C, Newbatt Y, Douglas L, et al. High-throughput screening assay for identification of small molecule inhibitors of Aurora2/STK15 kinase. J Biomol Screen 2004;9:391-6
  • McDonald OB, Chen WJ, Ellis B, et al. A scintillation proximity assay for the Raf/MEK/ERK kinase cascade: high-throughput screening and identification of selective enzyme inhibitors. Anal Biochem 1999;268:318-29
  • Angeles TS, Steffler C, Bartlett BA, et al. Enzyme-linked immunosorbent assay for trkA tyrosine kinase activity. Anal Biochem 1996;236:49-55
  • Newbatt Y, Burns S, Hayward R, et al. Identification of inhibitors of the kinase activity of oncogenic V600EBRAF in an enzyme cascade high-throughput screen. J Biomol Screen 2006;11:145-54
  • Mathis G. HTRF technology. J Biomol Screen 1999;4:309-13
  • Mathis G. Probing molecular interactions with homogeneous techniques based on rare earth cryptates and fluorescence energy transfer. Clin Chem 1995;41:1391-7
  • Mathis G. Rare earth cryptate and homogeneous fluoroimmunoassays with human sera. Clin Chem 1993;39:1953-9
  • Hemmilä I. LANCE: homogeneous assay platform for HTS. J Biomol Screen 1999;4:303-7
  • Moshinsky DJ, Ruslim L, Blake RA, Tang F. A widely applicable, high-throughput TR-FRET assay for the measurement of kinase autophosphorylation: VEGFR-2 as a prototype. J Biomol Screen 2003;8:447-52
  • von Ahsen O, Schmidt A, Klotz M, Parczyk K. Assay concordance between SPA and TR-FRET in high-throughput screening. J Biomol Screen 2006;11:606-16
  • Jia Y, Quinn CM, Gagnon AI, Talanian R. Homogeneous time-resolved fluorescence and its applications for kinase assays in drug discovery. Anal Biochem 2006;356:273-81
  • Seethala R, Menzel R. A homogeneous, fluorescence polarization assay for Src-family tyrosine kinases. Anal Biochem 1997;253:210-8
  • Seethala R, Menzel R. A fluorescence polarization competition immunoassay for tyrosine kinases. Anal Biochem 1998;255:257-62
  • Seethala R. Fluorescence polarization competition immunoassay for tyrosine kinases. Methods 2000;22:61-70
  • Klumpp M, Boettcher A, Becker D, et al. Readout technologies for highly miniaturized kinase assays applicable to high-throughput screening in a 1536-well format. J Biomol Screen 2006;11:617-33
  • Hubert CL, Sherling SE, Johnston PA, Stancato LF. Data concordance from a comparison between filter binding and fluorescence polarization assay formats for identification of ROCK-II inhibitors. J Biomol Screen 2003;8:399-409
  • Parker GJ, Law TL, Lenoch FL, Bolger RE. Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand-binding and kinase/phosphatase assays. J Biomol Screen 2000;5:77-88
  • Fowler A, Swift D, Longman E, et al. An evaluation of fluorescence polarization and lifetime discriminated polarization for high throughput screening of serine/threonine kinases. Anal Biochem 2002;308:223-31
  • Coffin J, Latev M, Bi X, Nikiforov TT. Detection of phosphopeptides by fluorescence polarization in the presence of cationic polyamino acids: application to kinase assays. Anal Biochem 2000;278:206-12
  • Burke TJ, Loniello KR, Beebe JA, Ervin KM. Development and application of fluorescence polarization assays in drug discovery. Comb Chem High Throughput Screen 2003;6:183-94
  • Owicki JC. Fluorescence polarization and anisotropy in high throughput screening: perspectives and primer. J Biomol Screen 2000;5:297-306
  • Warner G, Illy C, Pedro L, et al. AlphaScreen kinase HTS platforms. Curr Med Chem 2004;11:721-30
  • Leoprechting SV, Kumpf R, Menzel S, et al. Miniaturization and validation of a high-throughput serine kinase assay using the Alpha Screen plateform. J Biomol Screen 2004;9:719-25
  • Wu X, Sills MA, Zhang JH. Further comparison of primary hit identification by different assay technologies and effects of assay measurement variability. J Biomol Screen 2005;10:581-9
  • Burns S, Travers J, Collins I, et al. Identification of small-molecule inhibitors of protein kinase B (PKB/AKT) in an AlphaScreen™ high-throughput Screen. J Biomol Screen 2006;11:822-7
  • Turek-Etienne TC, Kober TP, Stafford JM, Bryant RW. Development of a fluorescence polarization AKT serine/threonine kinase assay using an immobilized metal ion affinity-based technology. Assay Drug Dev Technol 2003;1:545-53
  • Loomans EEMG, van Doornmalen AM, Wat JWY, Zaman GJR. High-throughput screening with immobilized metal ion affinity-based fluorescence polarization detection, a homogeneous assay for protein kinases. Assay Drug Dev Technol 2003;1:445-53
  • Gaudet EA, Huang K-S, Zhang Y, et al. A homogeneous fluorescence polarization assay adaptable for a range of protein serine/threonine and tyrosine kinases. J Biomol Screen 2003;8:164-75
  • Perrin D, Marin T, Cambet Y, et al. Overcoming the hurdle of fluorescence compounds in kinase screening: a case study. Assay Drug Dev Technol 2006;4:185-96
  • Singh P, Lillywhite B, Bannaghan C, Broad P. Using IMAP technology to identify kinase inhibitors: comparison with a substrate depletion approach and analysis of the nature of false positives. Comb Chem High Throughput Screen 2005;8:319-25
  • Wu G, Yuan Y, Hodge CN. Determining appropriate substrate conversion for enzymatic assays in high-throughput screening. J Biomol Screen 2003;8:694-700
  • Cohen CB, Chin-Dixon E, Jeong S, Nikiforov TT. A microchip-based enzyme assay for protein kinase A. Anal Biochem 1999;273:89-97
  • Perrin D, Fremaux C, Scheer A. Assay development and screening of a serine/threonine kinase in a on-chip mode using Caliper nanofluidics technology. J Biomol Screen 2006;11:359-68
  • Morgan AG, McCauley TJ, Stanaitis ML, et al. Development and validation of a fluorescence technology for both primary and secondary screening of kinases that facilitates compound selectivity and site-specific inhibitor determination. Assay Drug Dev Technol 2004;2:171-81
  • Xia W, Rininsland F, Wittenburg SK, et al. Applications of fluorescent polymer superquenching to high throughput screening assay for protein kinases. Assay Drug Dev Technol 2004;2:183-92
  • Wittenburg S, Stankewicz C, Rininsland F. Biotinylated peptides for rapid identification of substrates and inhibitors of kinases and phosphatases with fluorescence superquenching. Assay Drug Dev Technol 2006;4:535-43
  • Rininisland F, Xia W, Wittenburg S, et al. Metal ion-mediated polymer superquenching for highly sensitive detection of kinase and phosphatase activities. Proc Natl Acad Sci USA 2004;101:15295-300
  • Rodems SM, Hamman BD, Lin C, et al. A FRET-based assay platform for ultra-high density drug screening of protein kinases and phosphates. Assay Drug Dev Technol 2002;1:9-19
  • Johnson SR, Padmanabha R, Vaccaro W, et al. A simple strategy for mitigating the effect of data variability on the identification of active chemotypes from high-throughput screening data. J Biomol Screen 2007;12:276-84
  • Kupcho K, Somberg R, Bulleit B, Goueli SA. A homogeneous, nonradioactive high-throughput fluorogenic protein kinase assay. Anal Biochem 2003;317:210-7
  • Singh P, Harden BJ, Lillywhite BJ, Broad PM. Identification of kinase inhibitors by an ATP depletion method. Assay Drug Dev Technol 2004;2:161-9
  • Ishida A, Yoshikawa T, Kamidate T. Firefly bioluminescence assay of ATP using diethylaminoethyl-dextran as an enhancer in the presence of sodium chloride and ATP extractant. Anal Biochem 2003;316:127-30
  • Koresawa M, Okabe T. High-throughput screening with quantitation of ATP consumption: a universal non-radioisotope homogenous assay for protein kinase. Assay Drug Dev Technol 2004;2:153-60
  • Charter NW, Kauffman L, Singh R, Eglen RM. A generic homogenous method for measuring kinase and inhibitor activity via adenosine 5′-diphosphate accumulation. J Biomol Screen 2006;11:390-9
  • Gowan SM, Hardcastle A, Hallsworth AE, et al. Application of meso scale technology for the measurement of phosphoproteins in human tumor xenografts. Assay Drug Dev Technol 2007;5:391-401
  • Mellentin-Michelotti J, Evangelista LT, Swartzman EE, et al. Determination of ligand binding affinities for endogenous seven-transmembrane receptors using fluorometric microvolume assay technology. Anal Biochem 1999;272:182-90
  • Robers MB, Horton RA, Bercher MR, et al. High-throughput cellular assays for regulated posttranslational modifications. Anal Biochem 2008;372:189-97
  • Adams DG, Wang Y, Mak PA, et al. Cellular Ser/Thr kinase assays using generic peptide substrates. Curr Chem Genomics 2008;1:54-64
  • Melnick JS, Janes J, Kim S, et al. An efficient rapid system for profiling the cellular activities of molecular libraries. Proc Natl Acad Sci USA 2006;103:3153-8
  • Korn K, Krausz E. Cell-based high-content screening of small-molecule libraries. Curr Opin Chem Biol 2007;11:503-10
  • Carpenter AE. Image-based chemical screening. Nat Chem Biol 2007;3(8):461-5
  • Marine S, Zamiara E, Smith ST, et al. A miniaturized cell-based fluorescence resonance energy transfer assay for insulin-receptor activation. Anal Biochem 2006;355:267-77
  • Zhang J, Ma Y, Taylor SS, Tsien RY. Genetically encoded reporters of protein kinase A activity reveal impact of substrate tethering. Proc Natl Acad Sci USA 2001;98:14997-5002
  • Ting AY, Kain KH, Klemke RL, Tsien RY. Genetically encoded fluorescent reporters of protein tyrosine kinase activities in living cells. Proc Natl Acad Sci USA 2001;98:15003-8
  • Violin JD, Zhang J, Tsien RY, Newton AC. A genetically encoded fluorescent reporter reveals oscillatory phosphorylation by protein kinase C. J Cell Biol 2003;161:899-909
  • Zhang L, Lee KC, Bhojani MS, et al. Molecular imaging of Akt kinase activity. Nat Med 2007;13:1114-9
  • Daley GQ, Baltimore D. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. Proc Natl Acad Sci USA 1988;85:9312-6
  • Beasley JR, McCoy PM, Walker TL, Dunn DA. Miniaturized, ultra-high throughput screening of tyrosine kinases using homogeneous, competitive fluorescence immunnoassays. Assay Drug Dev Technol 2004;2:141-51
  • Pommereau A, Pap E, Kannt A. Two simple and generic antibody-independent kinase assays: comparison of a bioluminescent and a microfluidic assay format. J Biomol Screen 2004;9:409-16

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.